Biomedical Applications of Engineered Antibodies
This free workshop will focus on the latest developments in antibody engineering across a variety of applications that include diagnostic/bioanalytical reagents and associated medical devices, imaging/theranostics, biologic medicines and targeted nanomedicines.
This workshop, run jointly by the CBNS and the Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland, provides a day of seminars from invited local and international experts focused on key techniques in antibody engineering, cloning/expression, sequence design/mutation, scale-up etc.
Time: 8.30-5.30pm, Friday 27 November 2015
Location: Advanced Engineering Building’s Auditorium, UQ St Lucia Campus
- Dr Kris Thurecht (UQ-AIBN/Centre for Advanced Imaging (CAI))
- Prof Frederic Meunier (UQ Queensland Brain Institute (QBI))
- Mr Geoff Osborne (UQ-QBI)
- Prof Matt Trau (UQ-AIBN)
- Dr Chris Howard (UQ-AIBN)
- A/Prof Daniel Christ (Garvan Institute of Medical Research)
- Prof Karlheinz Peter (Baker IDI Heart and Diabetes Institute)
- Dr Angus Johnston (Monash Institute for Pharmaceutical Sciences)
- Dr Ben Keifel (co-founder and CEO, affinity BIO)
- Dr Douglas Campbell (Minomic)
- Dr Con Panousis (Director, Antibody Technologies, CSL)
- Dr Peter Hudson (CSO, Avipep)
- Prof David Irving (Executive Director, R&D, Australian Red Cross Blood Service)
A flyer for the workshop is available for download.
To assist us with catering, which will be provided on the day, please register by Friday 13 November via email: email@example.com